The May 30, 2024 investor call in the last couple

The May 30, 2024 investor call in the last couple of minutes mentioned that the Glioblastoma study was now underway after unavoidable delays, and that results of the study would be by the end of the year.

There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.